Abdullah Alajati
4PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.Racha Hosni, Niklas Klümper, Christine Sanders
|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.Racha Hosni, Niklas Klümper, Christine Sanders
|Jan 04, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.Sana Hosni, Viola Kilian, Niklas Klümper
|Dec 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.Niklas Klümper, Damian J Ralser, Jörg Ellinger
Pageof 1
Frequent Collaborators
4 joint publications
Niklas Klümper
4 joint publications
Michael Hölzel
4 joint publications
Marieta Toma
3 joint publications
Damian J Ralser
3 joint publications
Sana Hosni
3 joint publications
Glen Kristiansen
2 joint publications
Markus Eckstein
2 joint publications
Manuel Ritter
2 joint publications
Maria A Gonzalez-Carmona
2 joint publications
Racha Hosni
